Southern Tick-Associated Rash Illness

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Investigation of Southern Tick-Associated Rash Illness (STARI)N/A1 trial
Active Trials
NCT00358761TerminatedEst. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allergy TherapeuticsInvestigation of Southern Tick-Associated Rash Illness (STARI)

Clinical Trials (1)

NCT00358761Allergy TherapeuticsInvestigation of Southern Tick-Associated Rash Illness (STARI)

Investigation of Southern Tick-Associated Rash Illness (STARI)

Start: Jul 2006Est. completion: Dec 2012
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space